Nursing care
Hypercalcemia nursing care: what to assess and what to do first
Written and reviewed by Dana Whitfield, RN, MSN · 5 min read · Updated September 2026
Short answer
Hypercalcemia is a serum calcium above 10.5 mg/dL (2.6 mmol/L), most often from hyperparathyroidism or malignancy, and it slows almost everything in the body: the gut, the muscles, the kidneys, and mental status. Expect lethargy, constipation, and a history that may include kidney stones. First-line treatment is IV isotonic saline and mobilisation, not a drug, unless the level is dangerously high.
What it is and why it happens
Hypercalcemia means a serum calcium above roughly 10.5 mg/dL (2.6 mmol/L). The two causes that account for most cases are primary hyperparathyroidism, where an overactive or adenomatous parathyroid gland oversecretes PTH and pulls calcium from bone, and malignancy, where certain tumours secrete PTH-related protein or cause direct bone destruction through metastases, most notably in breast cancer, lung cancer, and multiple myeloma.
Other contributors include prolonged immobility, which shifts calcium out of bone through disuse, thiazide diuretics, which reduce renal calcium excretion, and excess vitamin D or calcium supplementation. Whatever the cause, the physiological effect is the same: calcium in excess slows smooth muscle, skeletal muscle, and neural conduction, which is why the presentation reads as a generalised slowing of the body rather than a localised problem.
How it presents — what you will actually see
Think of hypercalcemia as a whole-body slowdown. Lethargy and generalised weakness are usually the earliest and most consistent findings, often dismissed by the patient as simply being tired. Constipation follows from reduced gut motility, and in a patient who also reports polyuria and increased thirst, the combination points toward calcium rather than a primary GI or endocrine cause on its own.
A history of kidney stones is a clue worth asking about directly, since chronic hypercalcemia from primary hyperparathyroidism often presents this way over months or years before it is diagnosed on a routine chemistry panel. In severe or acute hypercalcemia, expect confusion progressing to lethargy and eventually stupor, along with a shortened QT interval on ECG and, less commonly, bradyarrhythmias. Bone pain is a feature specific to malignancy-related hypercalcemia and hyperparathyroidism, reflecting the underlying bone turnover driving the calcium up.
Nursing assessment priorities
Ask specifically about constipation, thirst, and urine output, and about any history of kidney stones, since these are the symptoms patients tend to normalise rather than volunteer. Assess mental status against baseline; a subtle slide from alert to lethargic in an at-risk patient (known malignancy, prolonged bedrest, hyperparathyroidism) is a meaningful finding, not just fatigue.
Review the ionised versus total calcium in light of albumin, and check the ECG for a shortened QT interval, which tracks with severity in acute hypercalcemia. Assess hydration status closely: hypercalcemia impairs the kidney's ability to concentrate urine, so patients are often significantly volume-depleted despite reporting thirst and drinking, and that volume status determines how aggressively fluids should be given. Review the medication list for thiazides, lithium, and vitamin D or calcium supplements, and check for prolonged immobility as a contributing factor.
Interventions and what to do first
The first intervention is IV isotonic (0.9%) saline, which restores volume and promotes renal calcium excretion, and mobilisation, since even short periods out of bed reduce the bone resorption that immobility drives. These two measures come before any calcium-lowering drug in almost every case, and for mild, asymptomatic hypercalcemia they may be sufficient on their own.
For higher or symptomatic levels, bisphosphonates (such as zoledronic acid) are the mainstay for malignancy-related hypercalcemia, though their effect takes 2-4 days to peak, so they are started early rather than held back. Calcitonin acts faster but for a shorter duration and is used as a bridge while a bisphosphonate takes effect. Loop diuretics are not first-line and are used cautiously, only once the patient is adequately volume-replete, since giving a diuretic to a volume-depleted patient worsens the problem rather than fixing it. Dialysis is reserved for severe hypercalcemia with renal failure or when the level is life-threatening and unresponsive to the above.
Complications to watch for
Cardiac risk centres on a shortened QT interval and bradyarrhythmia, so a hypercalcemic patient on telemetry needs the ECG reviewed specifically for QT shortening, and any digoxin on the medication list needs extra caution since hypercalcemia increases sensitivity to digoxin toxicity.
Renal risk runs in two directions: acute impairment from volume depletion and nephrocalcinosis from calcium deposition in the renal tubules over time, and the chronic risk of recurrent kidney stones in patients with long-standing hyperparathyroidism. Pathological fracture is a risk in malignancy-related hypercalcemia where bone is actively being resorbed, so falls and unexplained bone pain in this population deserve more than routine attention. Left uncorrected, hypercalcemia can progress to a hypercalcemic crisis: severe dehydration, altered mental status, and cardiac instability that requires urgent treatment.
Patient teaching before discharge
Encourage adequate fluid intake and regular ambulation, since both directly counter the mechanisms that raise calcium: dehydration concentrates it, and immobility releases it from bone. This is the same message given as an inpatient intervention, and it holds just as true once the patient is home.
Advise against excess vitamin D or calcium supplementation unless specifically directed by the prescriber, and review any thiazide diuretic on the discharge medication list, since it may need to be changed if hypercalcemia was contributing. Patients with primary hyperparathyroidism should understand that surgery (parathyroidectomy) is often the definitive treatment, and that ongoing monitoring of calcium levels is how recurrence or undertreatment is caught. Teach the patient to recognise returning lethargy, worsening constipation, or new bone pain as reasons to contact the clinic rather than waiting for the next scheduled lab draw.
The next step on this is the same as on everything else here: answer questions and read the rationales. Our renal and genitourinary practice questions are the closest set to what this page covers.
Common questions
What is the first-line treatment for hypercalcemia?
IV isotonic saline and mobilisation, given before any calcium-lowering drug in nearly all cases. Saline restores volume and helps the kidneys excrete calcium, while getting the patient out of bed reduces the bone resorption that immobility drives.
Why does hypercalcemia cause constipation?
Excess calcium slows smooth muscle contraction throughout the gut, reducing motility. Combined with the volume depletion hypercalcemia also causes, this makes constipation one of the more consistent early complaints alongside lethargy.
Why are loop diuretics not first-line for hypercalcemia?
Hypercalcemic patients are typically volume-depleted because the kidney cannot concentrate urine properly, and giving a diuretic before restoring volume worsens dehydration and can raise calcium further. Isotonic saline corrects the volume deficit first; diuretics are used cautiously afterward if needed.
How quickly do bisphosphonates work for malignancy-related hypercalcemia?
They take roughly 2-4 days to reach peak effect, so they are started early rather than held back for a severe level. Calcitonin is used alongside as a faster-acting bridge because its own effect wears off within a few days.
What ECG change should you look for in hypercalcemia?
A shortened QT interval is the characteristic finding, and it tends to track with the severity of the calcium elevation. Review telemetry patients specifically for this, and watch for increased digoxin sensitivity if the patient is on that medication.